SAN DIEGO, Oct. 16, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or otherwise acquired D-Wave (NYSE: QBTS) securities between February 26, 2026 and August 25, 2026, inclusive (the "Class Period"). D-Wave is a company engaged in quantum computing.

The complaint alleges that D-Wave overstated its business and financial prospects.

Investors who purchased D-Wave Quantum Inc. securities during the Class Period and suffered significant losses should contact Robbins LLP before December 15, 2026 for information about the lawsuit.

Why Was D-Wave Sued?

According to the complaint, during the Class Period, defendants failed to disclose that:

(i) defendants materially overstated D-Wave's business and financial prospects;

(ii) the foregoing was reasonably likely to negatively impact the Company's business and reputation; and

(iii) as a result, defendants' public statements were materially false and misleading at all relevant times.

Why Did D-Wave Stock Drop?

According to the complaint, the truth started to emerge on August 6, 2026, when D-Wave announced its financial results for the second quarter of 2026. Among other things, D-Wave reported revenue of just $3.08 million, compared to $3.1 million for the same period in the prior year, falling short of analyst expectations ranging from $4.03 million to $4.08 million. On this news, D-Wave's stock price declined $1.99 per share, or 9.28%, to close at $19.41 per share on August 6, 2026.

Then, on August 25, 2026, D-Wave issued a press release "announc[ing] that John Markovich is retiring and thus resigning from his position as Chief Financial Officer effective September 2, 2026." On this news, D-Wave's stock price fell $1.84 per share, or 9.51%, closing at $17.51 per share on August 26, 2026.

What Can D-Wave Shareholders Do Now?

Investors who purchased D-Wave Quantum Inc. securities during the Class Period may be eligible to serve as lead plaintiff. The lead plaintiff is a court-appointed investor who represents the interests of all class members throughout the litigation. Stockholders who wish to seek appointment as lead plaintiff should contact Robbins LLP before the December 15, 2026 deadline for information about the appointment process.

Shareholders do not need to serve as lead plaintiff to share in any potential recovery. Investors who do not seek appointment may remain absent class members.

Does It Cost Anything to Participate?

No. Robbins LLP represents investors on a contingency fee basis, with no upfront or out-of-pocket fees or expenses.

Contact Robbins LLP

Investors seeking additional information about the D-Wave Quantum Inc. securities class action may contact Robbins LLP by submitting an inquiry, emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003.

Why Robbins LLP?

A recognized leader in shareholder rights litigation, Robbins LLP represents investors in securities fraud and shareholder derivative litigation. We have helped restore more than $2 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history.

"Companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against D-Wave Quantum Inc. settles, or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

SOURCE Robbins LLP

Share this article

askROI Offers an All-in-One Platform Featuring More Than 240 Productivity Tools, Generative AI, Business Automation and Advanced AI Research

LAS VEGAS, Oct. 16, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company ("Hyperscale Data" or the "Company"), today announced that its subsidiary, askROI, Inc. ("askROI"), an AI technology company, is preparing to become a separate, publicly traded company, whether through a reverse takeover ("RTO"), an initial public offering of askROI's securities ("IPO"), or through the use of a special purpose acquisition company (a "SPAC" and collectively with the RTO and the IPO, a "Transaction"). The Company and askROI are targeting a consummated Transaction by the second or third quarter of 2027, depending upon the type of transaction that the Company ultimately determines to pursue, and if the Transaction constitutes an RTO, the completion of the subsequent filing of a resale registration statement registering the shares of the current public company, which has not been identified, that the Company would receive in the RTO in consideration for the Company's sale of askROI to it in the first half of 2027, subject to the completion of necessary financial and regulatory requirements, as well as prevailing market conditions.

askROI is an AI technology company offering an all-in-one AI productivity, research, automation and content creation platform. Available through web and mobile applications, askROI provides access to leading AI models, more than 240 productivity tools, custom AI applications, enterprise knowledge management capabilities and generative AI technologies. The platform serves individuals, entrepreneurs, professionals and businesses seeking to leverage artificial intelligence to improve productivity, automate workflows and accelerate innovation. For more information, visit www.askROI.com.

The intended public listing represents another step in Hyperscale Data's broader strategy to unlock stockholder value by positioning its operating businesses to pursue independent growth opportunities and establish separate market valuations.

In connection with the preparation of the Transaction, Milton "Todd" Ault III will step down as Chief Executive Officer of askROI and askROI is expected to appoint Joseph Spaziano as Chief Executive Officer and Ryan Doucette as President. Mr. Spaziano, who currently serves as Chief Technology Officer of Hyperscale Data, as well as President and Chief Operating Officer of askROI, would step down from his role at Hyperscale Data to focus solely on askROI. Mr. Doucette currently serves as Head of Product at askROI. The Company currently anticipates, but cannot state with any certainty, that Messrs. Spaziano and Doucette would continue in these positions subsequent to any Transaction.

The planned leadership transition is intended to provide askROI with a dedicated management team focused on scaling its AI platform and positioning the company for independent operations.

Milton "Todd" Ault III, Founder and Executive Chairman of Hyperscale Data, commented: "We believe there is incredible value in askROI, which is currently not being recognized by the public markets while it is a subsidiary of Hyperscale Data. We also believe comparable AI technology companies often trade at substantially higher valuations, and we further believe that the stockholders of the Company would benefit from having askROI be a separate entity and have the ability to establish its own independent market value since we expect that such a separation could enhance the market capitalization of the Company by virtue of its ownership of a post-Transaction public entity. Finally, we expect this planned public listing can benefit Hyperscale Data stockholders, as well as future askROI shareholders, by providing greater transparency into the value of the business while creating a platform for future growth, access to capital and long-term shareholder value creation."

The Company expects to provide additional information regarding the transaction structure, corporate organization and listing timetable for the planned public listing of askROI at a later date. There can be no assurance that the proposed public listing will occur within the anticipated timeframe or at all.

The planned public listing of askROI is consistent with Hyperscale Data's broader strategy of evaluating opportunities to establish independent market valuations for its portfolio businesses. Management believes that separating certain operating businesses into independently valued enterprises could provide investors with greater transparency into the underlying assets and operations of Hyperscale Data. The Company intends to continue evaluating strategic alternatives for its subsidiaries and investments as it seeks to maximize long-term stockholder value.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data's public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data's wholly owned subsidiaries, Ault Capital Group, Inc. ("ACG"), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the "Divestiture") to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data's headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential," or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company's business and financial results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company's website at hyperscaledata.com.

SOURCE Hyperscale Data Inc.

Share this article

BUUU Group Limited Announces 10-for-1 Forward Share Split

SINGAPORE, Oct. 16, 2026 /PRNewswire/ -- BUUU Group Limited (Nasdaq: BUUU) ("BUUU" or the "Company") today announced that its board of directors has approved a ten-for-one (10-for-1) forward split of the Company's ordinary shares, to be effected by subdividing each of the Company's issued and unissued Class A ordinary shares and Class B ordinary shares into ten shares of the same class (the "Share Subdivision"). The Share Subdivision is intended to make the Company's Class A ordinary shares more accessible to a broader base of investors and to enhance their trading liquidity. Subject to processing by Nasdaq, the Class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at market open on October 26, 2026, under the Company's existing symbol "BUUU."

The Share Subdivision follows BUUU's completion on September 15, 2026 of its acquisition of a 60% equity interest in Brightray Science Inc., through which the Company has established industrialized AI data center delivery as its core growth business.

Details of the Share Subdivision

Key date. The Class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at market open on October 26, 2026.

Ratio and mechanics. As a result of the Share Subdivision, each issued Class A ordinary share and each issued Class B ordinary share will be automatically subdivided into ten shares of the same class. As a result, each shareholder will hold ten shares of the relevant class for every share held immediately before the Share Subdivision (equivalent to nine additional shares for each share held). The Class A ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol "BUUU." The new CUSIP number of the Class A ordinary shares following the Share Subdivision will be G1739L110.

Authorized and outstanding shares. In connection with the Share Subdivision, the maximum number of shares the Company is authorized to issue will increase proportionately from 500,000,000 shares of no par value, divided into 250,000,000 Class A ordinary shares and 250,000,000 Class B ordinary shares, to 5,000,000,000 shares of no par value, divided into 2,500,000,000 Class A ordinary shares and 2,500,000,000 Class B ordinary shares.

Rights and ownership unchanged. The rights and restrictions attaching to each class of shares will remain unchanged, including the voting rights of one vote per Class A ordinary share and twenty votes per Class B ordinary share, and all shares of each class resulting from the Share Subdivision will rank pari passu in all respects with each other. The Share Subdivision will not change any shareholder's percentage ownership interest or voting power in the Company. No fractional shares will result from the Share Subdivision.

No action required unless you hold physical certificates. No action is required by shareholders. Shareholders who hold Class A ordinary shares through a bank, broker or other nominee will have their positions automatically adjusted to reflect the Share Subdivision, subject to their nominee's particular processes. The Company's transfer agent, VStock Transfer, LLC ("VStock"), will update the holdings of registered shareholders in book-entry form. Registered shareholders holding share certificates will be asked to deliver a letter of transmittal to VStock to surrender their certificates to VStock in exchange for the right to receive post-Share Subdivision ordinary shares in electronic, book-entry form.

Outstanding securities. Proportionate adjustments will be made, to the extent provided by their respective terms, to the number of Class A ordinary shares issuable upon the exercise, conversion or settlement of, and to the exercise price or other per-share terms of, the Company's outstanding warrants and other securities exercisable for, convertible into or settleable in Class A ordinary shares.

Approval. The Share Subdivision was approved by the Company's board of directors on September 28, 2026.

The Company will furnish a copy of this press release to the U.S. Securities and Exchange Commission (the "SEC") on Form 6-K.

About BUUU Group Limited

BUUU Group Limited (Nasdaq: BUUU) has established industrialized AI data center delivery as its core growth business, operated through Brightray Science Inc., in which BUUU acquired a controlling interest in September 2026. BUUU also provides meetings, incentives, conferences and exhibitions (MICE) solutions, including event management and stage production, for public institutions, agencies, real estate companies and established brands.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "would," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" and similar expressions. Forward-looking statements include statements regarding the expected timing and effectiveness of the Share Subdivision, including the date on which the Class A ordinary shares are expected to begin trading on a split-adjusted basis; the intended effects of the Share Subdivision, including on the accessibility and trading liquidity of the Class A ordinary shares; and the Company's business strategy and prospects. Such statements are based on current expectations and assumptions and involve risks and uncertainties, many of which are beyond the control of BUUU, that could cause actual results to differ materially from those contained in the forward-looking statements. These risks and uncertainties include, but are not limited to: delays in, or the failure to complete, the steps required to implement the Share Subdivision, including registration of the amendment to the Company's memorandum and articles of association in the British Virgin Islands and processing by Nasdaq, The Depository Trust Company, the Company's transfer agent and brokers; the possibility that the Share Subdivision does not achieve its intended effects, including any improvement in trading liquidity or broadening of the Company's investor base; the market price and trading volume of the Class A ordinary shares following the Share Subdivision, which may not adjust proportionately to the Share Subdivision, and the possibility of increased volatility; the effect of a lower per-share trading price on the Company's continued compliance with Nasdaq listing requirements, including the minimum bid price requirement; the integration of Brightray into BUUU; competition in the data center industry; demand for AI computing infrastructure; changes in laws and regulations affecting the data center and AI computing industries, including trade and export control measures; and other risks described in BUUU's filings with the SEC, including its most recent annual report on Form 20-F. Forward-looking statements speak only as of the date of this press release, and BUUU undertakes no obligation to update any forward-looking statement, except as required by applicable law.

SOURCE BUUU Group Limited

Share this article

BRAEMAR HOTELS & RESORTS DECLARES PREFERRED DIVIDENDS FOR THE FOURTH QUARTER OF 2026

DALLAS, Oct. 16, 2026 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE: BHR) ("Braemar" or the "Company") today announced that its Board of Directors (the "Board") declared a quarterly cash dividend for the fourth quarter ending December 31, 2026 for the Company's 5.5% Series B Cumulative Convertible Preferred Stock equal to: $0.3438 per share, which will be paid on January 15, 2027 to stockholders of record as of December 30, 2026.

The Board declared a quarterly cash dividend for the fourth quarter ending December 31, 2026 for the Company's 8.25% Series D Cumulative Preferred Stock equal to: $0.5156 per share, which will be paid on January 15, 2027 to stockholders of record as of December 31, 2026.

The Board declared a monthly cash dividend for all CUSIPs of the Company's Series E Redeemable Preferred Stock, payable as follows: $0.15625 per share will be paid on November 16, 2026, to stockholders of record as of October 30, 2026; $0.15625 per share will be paid on December 15, 2026 to stockholders of record as of November 30, 2026; and $0.15625 per share will be paid on January 15, 2027 to stockholders of record as of December 31, 2026.

The Board declared a monthly cash dividend for CUSIPs 10482B705 and 10482B887 of the Company's Series M Redeemable Preferred Stock payable as follows: $0.18125 per share will be paid on November 16, 2026, to stockholders of record as of October 30, 2026; $0.18125 per share will be paid on December 15, 2026 to stockholders of record as of November 30, 2026; and $0.18125 per share will be paid on January 15, 2027 to stockholders of record as of December 31, 2026.

The Board declared a monthly cash dividend for CUSIPs 10482B796, 10482B861, 10482B770 and 10482B846 of the Company's Series M Redeemable Preferred Stock payable as follows: $0.17917 per share will be paid on November 16, 2026 to stockholders of record as of October 30, 2026; $0.17917 per share will be paid on December 15, 2026 to stockholders of record as of November 30, 2026; and $0.17917 per share will be paid on January 15, 2027 to stockholders of record as of December 31, 2026.

The Board declared a monthly cash dividend for CUSIP 10482B820 of the Company's Series M Redeemable Preferred Stock payable as follows: $0.17708 per share will be paid on November 16, 2026, to stockholders of record as of October 30, 2026; $0.17708 per share will be paid on December 15, 2026 to stockholders of record as of November 30, 2026; and $0.17708 per share will be paid on January 15, 2027 to stockholders of record as of December 31, 2026.

As of September 30, 2026, there were 8,150,132 shares of the Company's Series E Redeemable Preferred Stock and 1,269,981 shares of the Company's Series M Redeemable Preferred Stock issued and outstanding, and there were an additional 2,448,062 shares of the Company's Series E Redeemable Preferred Stock and 91,129 shares of the Company's Series M Redeemable Preferred Stock issued and outstanding for which redemption requests have been received but have not been fully processed.

About Braemar Hotels & Resorts

Braemar Hotels & Resorts Inc. (NYSE: BHR) is a real estate investment trust (REIT) focused on the high-growth luxury hotel and resort sector. Its industry-leading portfolio features luxury properties across the United States and the U.S. territories in the Caribbean.

Forward-Looking Statements

Certain statements and assumptions in this press release contain or are based upon "forward-looking" information and are being made pursuant to the safe harbor provisions of the federal securities regulations. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "may," "will," "should," "potential," "intend," "expect," "anticipate," "estimate," "approximately," "believe," "could," "project," "predict," or other similar words or expressions. Additionally, statements regarding the following subjects are forward-looking by their nature: our business and investment strategy; anticipated or expected purchases, sales or dispositions of assets; our projected operating results; completion of any pending transactions; our ability to restructure existing property-level indebtedness; our ability to secure additional financing to enable us to operate our business; our understanding of our competition; projected capital expenditures; and the impact of technology on our operations and business. Such forward-looking statements are based on our beliefs, assumptions, and expectations of our future performance taking into account all information currently known to us. These beliefs, assumptions, and expectations can change as a result of many potential events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, results of operations, plans, and other objectives may vary materially from those expressed in our forward-looking statements. You should carefully consider this risk when you make an investment decision concerning our securities. These and other risk factors are more fully discussed in the Company's filings with the SEC.

The forward-looking statements included in this press release are only made as of the date of this press release. Investors should not place undue reliance on these forward-looking statements. We will not publicly update or revise any forward-looking statements, whether as a result of new information, future events or circumstances, changes in expectations or otherwise except to the extent required by law.

SOURCE Braemar Hotels & Resorts, Inc.

Share this article

NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a pioneer in the development of targeted radiotherapies, today announced inducement equity awards to Matt David, M.D., the Company's newly appointed Chief Financial Officer, and Sean Maenpaa, the Company's newly appointed Senior Vice President, Business Development.

In connection with Dr. David's appointment, on October 14, 2026 the Company granted Dr. David a non-qualified stock option to purchase 250,000 shares of the Company's common stock at an exercise price of $0.97 per share, equal to the closing price of Actinium's common stock on the NYSE American on October 14, 2026. The option has a ten-year term; 28% of the shares underlying the option vest on the first anniversary of the grant date, and the remainder vest in equal monthly installments of 2% of the shares underlying the option over the following 36 months. Dr. David was also granted 250,000 restricted stock units ("RSUs"), of which 125,000 vest in three equal annual installments on the first, second and third anniversaries of the grant date and 125,000 vest in full on the third anniversary of the grant date, as well as up to 75,000 RSUs that vest upon the achievement of specified corporate milestones.

In connection with Mr. Maenpaa's appointment, on October 12, 2026 the Company granted Mr. Maenpaa a non-qualified stock option to purchase 40,000 shares of the Company's common stock at an exercise price of $1.06 per share, equal to the closing price of Actinium's common stock on the NYSE American on October 12, 2026. The option has a ten-year term; 28% of the shares underlying the option vest on the first anniversary of the grant date, and the remainder vest in equal monthly installments of 2% of the shares underlying the option over the following 36 months. Mr. Maenpaa was also granted 20,000 RSUs that vest in three equal annual installments on the first, second and third anniversaries of the grant date, and 50,000 RSUs that vest on the third anniversary of the grant date, subject to the fulfillment of certain corporate milestones.

Vesting of each award is subject to the executive's continued service with the Company through the applicable vesting date. The awards were granted outside of the Company's Amended and Restated 2019 Stock Plan as an inducement material to each executive's entering into employment with the Company in accordance with Section 711(a) of the NYSE American Company Guide, and are subject to the terms of the Actinium Pharmaceuticals, Inc. 2026 Employment Inducement Award Plan and the applicable award agreements.

About Actinium Pharmaceuticals, Inc.

Actinium is a pioneer in targeted radiotherapies designed to improve outcomes for patients with cancer. The company employs a biology-driven approach to develop differentiated radiopharmaceuticals for solid tumors and hematologic malignancies. Its mission is to transform cancer treatment through innovative radioconjugates that maximize therapeutic efficacy while minimizing toxicity to healthy tissue by combining expertise in tumor biology, translational medicine, and radiochemistry. Since inception, Actinium has focused on developing innovative radiotherapies. Its pipeline reflects this strategy across three areas: (1) solid tumor therapeutics including ATNM-400 and Actimab-A with pan-tumor potential; (2) Actimab-A as a therapeutic backbone for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in collaboration with the National Cancer Institute (NCI); and (3) targeted conditioning agents including Iomab-B for bone marrow transplant and Iomab-ACT for cell and gene therapy conditioning. ATNM-400 targets a novel antigen distinct from PSMA and has demonstrated preclinical activity across metastatic castration-resistant prostate cancer (mCRPC), non-small cell lung cancer (NSCLC), and breast cancer, and is being evaluated in a first-in-human Phase 1 study in mCRPC. Actimab-A has shown improved survival in relapsed/refractory AML with CLAG-M and is advancing toward a Phase 2/3 trial, with additional development ongoing through a CRADA with the NCI. Actinium is also advancing preclinical solid tumor programs and holds ~250 patents and patent applications, including intellectual property related to cyclotron-based production of Ac-225. For more information, please visit www.actiniumpharma.com.

Forward-Looking Statements

This press release may contain projections or other "forward-looking statements" within the meaning of the "safe-harbor" provisions of the private securities litigation reform act of 1995 regarding future events or the future financial performance of the Company which the Company undertakes no obligation to update. These statements are based on management's current expectations and are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with the Company's ability to retain key personnel, the Company's ability to obtain additional financing on acceptable terms or at all, the conduct, timing and results of the Company's clinical trials, estimates of potential markets for drugs under development, clinical trials, actions by the FDA and other governmental agencies, regulatory clearances, responses to regulatory matters, the market demand for and acceptance of Actinium's products and services, performance of clinical research organizations and other risks detailed from time to time in Actinium's filings with the Securities and Exchange Commission (the "SEC"), including without limitation its most recent annual report on form 10-K, subsequent quarterly reports on Forms 10-Q and Forms 8-K, each as amended and supplemented from time to time.

Investors: [email protected]

SOURCE Actinium Pharmaceuticals, Inc.

Share this article

NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP continues to expand its Real Estate Practice with the addition of attorneys Tiana DeLeo Dunn in San Francisco and Shane C. Griffin in Denver, further strengthening the firm's commercial real estate and digital infrastructure capabilities nationwide.

Dunn joins from Jackson Walker LLP and Griffin joins from Brownstein Hyatt Farber Schreck. Together, they bring significant experience advising developers, owners, investors, landlords, tenants, lenders, and other market participants on sophisticated real estate matters spanning a broad range of asset classes and industries.

Known for her retail leasing and development practice, Dunn advises shopping center developers, owner-operators, landlords, and tenants on complex leasing, development, and operational matters. Her practice also includes data center leasing and other digital-infrastructure-related real estate matters. She additionally represents clients in restructurings and workouts involving commercial real estate assets, helping preserve value and position portfolios for long-term success.

Griffin advises developers, institutional owners, investors, and lenders on complex transactions across various asset classes, including office, multifamily, industrial, and data center projects. He is particularly known for his work on office and mixed-use developments in the Denver market, where he has advised on prominent projects throughout Lower Downtown, River North, Cherry Creek, and the Central Business District.

The arrivals of Dunn and Griffin continue the recent expansion of Greenberg Traurig's 720-plus-attorney Global Real Estate Practice. Since May, the team also has welcomed Shareholders Joseph W. Creech in Washington, D.C., Carlos Freaner in Mexico, Brian L. Helweil in New York City, Ben Patton in London, Jennifer Polovetsky in New York City and Long Island, Grant Puleo in San Diego, William ("Bill") J. Shaughnessy in Atlanta, Carlos A. Sugich in Phoenix and Mexico, and Patrick Williams in London.

"Tiana and Shane are outstanding additions to our Global Real Estate Practice, and their arrival reflects our strong commitment to attracting the very best legal talent in key markets across the United States and worldwide," Greenberg Traurig Chief Executive Officer Brian L. Duffy said. "Clients value Tiana and Shane for their practical, business-oriented approach to helping them navigate sophisticated real estate matters and for keeping their strategic goals front and center throughout negotiations."

"Our growth strategy is driven by client needs and where we see opportunities to add meaningful capabilities," Greenberg Traurig Co-President and Global Real Estate Practice Co-Chair Michael J. Baum said. "Tiana's and Shane's experience across commercial leasing, development, institutional transactions, and digital infrastructure matters aligns directly with the demand we are seeing across our platform."

During her 20-year legal career, Dunn has advised clients on a broad range of significant commercial real estate transactions, including acquisition financing for three fully occupied Class A retail shopping centers valued at a combined $126 million, and a $100 million commercial mortgage-backed security loan supporting a 1 million-square-foot Class A shopping center. She also has represented a major real estate development group in the negotiation of office and retail leases and advised on the development and leasing of a 971-acre business park with 7 million square feet of industrial and corporate space.

"Greenberg Traurig has built one of the world's premier real estate platforms, and that reputation is a significant reason I chose to join the firm," Dunn said. "Real estate has been a core strength of Greenberg Traurig for decades, and the firm's depth of experience, global reach, and collaborative culture create an outstanding environment for serving clients. I'm excited to work alongside my new colleagues to advise clients on sophisticated leasing, development, and data-center-related matters."

Griffin's experience includes advising some of the nation's leading real estate owners, developers, and investors, including Hines, Invesco, Rockefeller Group, Related Companies, and other institutional market participants.

Among his notable representations, he advised a joint venture between Hines, Perlmutter, and a major financial institution in the sale of 1601 Wewatta, a newly constructed office tower near Denver's Union Station. Valued at approximately $225 million, the transaction marked the highest per-square-foot office sale price in Colorado history and was negotiated and closed in fewer than 30 days.

"I have known and worked with a number of Greenberg Traurig attorneys over many years and have developed tremendous respect for their talent, professionalism, and client-focused approach," Griffin said. "The firm's market-leading global real estate platform, combined with its deep bench of talent across key markets, creates an exceptional opportunity to continue growing my practice while providing clients with the sophisticated, cross-disciplinary counsel they increasingly need to achieve their business objectives."

Dunn earned her J.D. from the South Texas College of Law Houston and her B.A. from the University of Florida. She is admitted to practice law in Texas and New York and plans to join the State Bar of California. Upon admission in California, she is expected to become a shareholder in Greenberg Traurig's San Francisco office. An active member of the International Council of Shopping Centers, Dunn also speaks regularly on retail leasing and commercial real estate topics.

Griffin earned his J.D. from the University of Colorado and his B.S. from Pepperdine University. He is a graduate of the Downtown Denver Partnership Leadership Program, reflecting his longstanding involvement in the city's business and development community.

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

SOURCE Greenberg Traurig, LLP

Share this article

WASHINGTON, Oct. 16, 2026 /PRNewswire/ -- Breast cancer is the most common cancer diagnosed in U.S. women. In hormone receptor positive, HER2 negative advanced cases, resistance to first line endocrine therapy is common. An estrogen receptor alpha gene mutation, ESR1m, drives resistance in nearly half of these patients, leaving them on ineffective treatment until radiologic progression is detected.

A new AMCP Market Insights Program, "Managed Care Approaches to ESR1-Mutated Advanced Breast Cancer," finds that biomarker testing and treatment paradigms are evolving faster than the evidence needed to manage them. Monitoring ESR1m prior to radiologic progression using circulating tumor DNA (ctDNA) liquid biopsy can enable an early switch to effective therapy timely treatment adjustment in order to extend time on first-line therapy. However, uncertainty around optimal testing parameters drives inconsistent testing practices, coverage friction across medical and pharmacy benefits, and care delays.

AMCP identified clear opportunities for payers to close these gaps. Recommendations include implementing flexible, evidence-based treatment pathways, aligning coverage policies across benefits, and streamlining prior authorization through auto-approvals for guideline-concordant testing, extended authorization durations, and gold carding. Payers also emphasize the need for total cost-of-care analyses that account for delayed progression rather than testing costs alone, alongside improved support for community oncologists and patient shared decision-making.

As next-generation selective estrogen receptor degraders move into earlier treatment lines, promoting testing consistency and multi-stakeholder alignment represents a critical opportunity to improve patient outcomes.

This program was independently conducted with funding support from AstraZeneca. The full peer-reviewed Market Insight supplement is published in the October 2026 edition of the Journal of Managed Care & Specialty Pharmacy.

SOURCE Academy of Managed Care Pharmacy

Share this article

Over 6,000 participants from North America gathered in Houston to celebrate progress and advancing opportunities for women in the building trades.

WASHINGTON, Oct. 16, 2026 /PRNewswire/ -- Thousands of tradeswomen, industry representatives, labor leaders, and allied organizations from across North America met in Houston, Texas, October 9–11 for the 2026 Tradeswomen Build Nations (TWBN) Conference, hosted by TradesFutures and with continued host sponsorship from North America's Building Trades Unions (NABTU).

Under the theme "Breaking Barriers, Expanding Horizons," the conference brought together unionized tradeswomen from across the United States and Canada for three days of education, professional development, networking, and collaboration. Plenary sessions, workshops and panel discussions celebrated women's contributions to the building trades and explored ways to help more women enter, succeed and lead in the union construction industry.

NABTU President and TradesFutures Board Chair, Sean McGarvey said, "Tradeswomen are essential to the strength and future of our industry. NABTU is proud to whole heartedly support Tradeswomen Build Nations and remains steadfastly committed to ensuring women are respected and uplifted in our industry and have access to all the resources, opportunities, training, and support they need to build successful careers in the unionized construction trades."

"Tradeswomen Build Nations shows what is possible when women have the opportunity to get started and the support to succeed," said TradesFutures Executive Director Marina Zhavoronkova. "The women gathered in Houston are building our infrastructure, supporting their families and opening doors for the next generation. TradesFutures is proud to bring them together and work alongside our partners to strengthen pathways into quality union apprenticeships and lasting careers."

Featured speakers included NABTU President Sean McGarvey; AFL-CIO President Liz Shuler; Megan Armstrong, president of Water Delivery at Kiewit; retired NASA astronaut Marsha Ivins; Ullico President and CEO Brian Hale; International Union of Operating Engineers General President John Downey; and SMART Director of Special Projects Louise Medina.

Throughout the conference, rank-and-file tradeswomen shared personal accounts of how onramp supportive programs, Registered Apprenticeships, and unionized construction careers changed their lives. Discussions highlighted workforce development, apprenticeship and training, physical safety, mental health and supportive jobsite cultures, emphasizing the opportunity and support women need to build lasting careers that sustain a middle-class life.

TradesFutures, NABTU and their partners will continue advancing apprenticeship readiness, recruitment, and retention efforts to help women enter and remain in the union construction workforce. The 2027 TWBN conference is scheduled for October 22-24, 2027, in Kansas City, Missouri.

For more photos, please click here.

Photo credits to Jake Hamm. 

About TradesFutures: TradesFutures is a leading national non-profit organization dedicated to expanding pathways into union Registered Apprenticeships and family-sustaining construction careers. Our network of more than 200 Apprenticeship Readiness Programs works across 32+ states, teaches the award-winning Multi-Craft Core Curriculum (MC3), and removes barriers to opportunity. Through proven strategies, programs, and partnerships, TradesFutures connects workers to quality careers while helping meet the evolving workforce needs of the union construction industry. Learn more about the work of TradesFutures here.

About NABTU: North America's Building Trades Unions is an alliance of 14 national and international unions in the building and construction industry that collectively represent over 3.2 million skilled craft professionals in the United States and Canada. Each year, our unions and signatory contractor partners invest over $2.5 billion in private-sector money to fund and operate over 1,900 apprenticeship training and education facilities across North America that produce the safest, most highly trained, and most productive skilled craft workers found anywhere in the world. NABTU is dedicated to creating economic security and employment opportunities for its construction workers by safeguarding wage and benefits standards, promoting responsible private capital investments, investing in renowned apprenticeship and training, and creating more construction career pathways to the middle class for women, communities of color, indigenous people, veterans, and the justice-involved. For more information, please visit nabtu.org.

SOURCE TradesFutures

Share this article

The need for these conversations is underscored by new survey findings revealing gaps in perceived support for mothers and awareness of maternal mental health resources. The survey found that less than half of American adults surveyed agree that mothers with children feel supported by those around them (47%), have opportunities to take time for themselves (42%), or have help caring for their children (41%). Additionally, only 28% of respondents say they are confident that most mothers experiencing mental health challenges after childbirth know where to seek help.

"Listening to moms, understanding their experiences, and ensuring their voices are heard are foundational to addressing the challenges we face," said Cindy Rahman, President and CEO, March of Dimes. "The Collective is about creating a space where moms feel supported and empowered, and inspiring all of us to continue to show up for one another in big and small ways. Through this effort, we are establishing a culture where every mom feels she can seek the care she needs, and where families, communities, and organizations come together to ensure no mom has to navigate motherhood alone."

As part of March of Dimes's It Starts With Mom campaign, The Collective's 2026 events in New York and Los Angeles are bringing together prominent voices from media, medicine, maternal and infant health, advocacy, and entertainment.

In New York, NBC4 anchor Natalie Pasquarella returned as emcee and opened the program with a fireside chat featuring Rahman. March of Dimes Chief Medical and Health Officer, Dr. Michael Warren, then moderated a panel featuring:

- Dr. Nastassia K. Harris, RNC-MNN, DNP, IBCLC

- Elizabeth Baron, licensed mental health counselor and psychotherapist specializing in maternal mental health

- Danielle Olivera, TV personality and NICU mom

- Dr. Jennifer Wider, women's health expert, author, and TV and radio personality

Next Friday in Los Angeles, Lanae Brody, entertainment and health reporter with California Post, will emcee the event. The day will begin with a fireside chat led by Karen Walker Johnson, CEO of Clever Care Health Plan and past March of Dimes Board of Trustees member, with California Surgeon General, Dr. Diana Ramos. Then, Dr. Warren will moderate a panel featuring:

- Lisa Schwartz, actor, digital creator, and maternal health advocate

- Sara Connell, bestselling author, speaker, and thought leadership expert

- Dr. Aaron Jordan Reitman, DO, Pediatric Neonatology, Kaiser Permanente

- Danielle Alura, international singer, model, actress, farmer, race car driver, and philanthropist.

Each event will also spotlight local programs with NewYork-Presbyterian, Stony Brook Children's Hospital (NY), and Cedars-Sinai supporting families in New York and Los Angeles.

The Collective is supported by a powerful group of partners whose ongoing collaboration fuels the March of Dimes mission. The Collective New York sponsors include premier sponsor Johnson & Johnson; supporting sponsors Philips Avent and The Honest Company; event sponsor Garrison Financial Group; in-kind partners Kendra Scott, Royce, and Maryellen; and media partners Audacy, Scary Mommy, and Romper. The Collective Los Angeles sponsors include premier sponsor: The Honest Company; and supporting sponsor Pampers. Additional It Starts with Mom campaign sponsors include; HCA Healthcare, Clearblue, and BD.

About March of Dimes

March of Dimes leads the fight for the health of all moms and babies. We support research, education, and advocacy, and provide programs and services so that every family can get the best possible start. Since 1938, we've built a successful legacy to support every pregnant person and every family. Visit marchofdimes.org for more information in multiple languages.

SOURCE March of Dimes

Share this article

The Article Explains How Investors Can Evaluate Rental Income, Property Expenses, and Potential Profits Before Purchasing an Investment Property.

FAYETTEVILLE, N.C., Oct. 16, 2026 /PRNewswire/ -- What should investors evaluate before purchasing an investment property? HelloNation has published an article that answers this question with insights from Amy Reynolds of ACE Real Estate & Property Management in Fayetteville, NC.

The article explains that estimating rental income accurately is one of the most important parts of evaluating an investment property. While a property may initially appear profitable, long-term rental profits often depend on local market conditions, vacancy trends, and total ownership costs. The article notes that careful financial planning can help investors avoid unrealistic expectations before deciding to buy.

According to the HelloNation article, one of the first steps in evaluating rental income is to compare similar rental homes in the same market. Investors are encouraged to review properties with similar layouts, square footage, condition, and neighborhood characteristics. Recently leased rental homes may offer a clearer picture of actual market demand than active listings alone. In Fayetteville, NC, rental prices may vary based on factors such as access to schools, local employers, and proximity to Fort Liberty.

The article also emphasizes the importance of studying vacancy trends before purchasing an investment property. Even homes with strong monthly rental income projections can become less profitable if vacancies occur frequently. Investors are encouraged to account for potential vacancy periods in their calculations rather than assuming continuous occupancy year-round. The article explains that conservative vacancy estimates often provide a more realistic view of annual cash flow.

Ownership expenses are another major focus. The HelloNation article explains that mortgage payments represent only part of the ongoing financial responsibilities associated with an investment property. Property taxes, insurance costs, maintenance, landscaping, repairs, and property management fees should all be included when calculating expected rental property profits. Older rental homes may require additional reserve funds due to aging systems or deferred maintenance.

The article also explains that newer investors commonly underestimate maintenance costs. Routine maintenance, appliance replacements, HVAC servicing, and tenant turnover expenses can gradually reduce rental income. Some property owners also maintain reserve funds for emergency repairs to reduce financial strain when unexpected issues arise. The article notes that accounting for these ownership expenses early may help investors better understand long-term profitability expectations.

Property management services are also discussed as part of a balanced investment strategy. The article explains that professional property management may include lease administration, tenant screening, maintenance coordination, rent collection, inspections, and communication support. Although these services reduce immediate monthly rental income, many investors view property management as valuable for supporting stable operations and reducing vacancy trends. The article notes that consistent oversight may also help preserve property condition and tenant retention.

For those evaluating opportunities in Fayetteville, NC, the article explains that rental income potential depends on several local market factors. Single-family rental homes near military housing demand may experience more stable interest rates, while other neighborhoods may show different pricing patterns. Property size, amenities, local supply levels, and condition all contribute to expected rental property profits.

The article also encourages investors to avoid relying solely on best-case projections. Inflated rental income estimates or underestimated ownership expenses can create financial challenges later. Instead, conservative financial analysis can help determine whether an investment property remains sustainable during slower market periods or when maintenance costs increase unexpectedly.

The article concludes that careful preparation before purchasing an investment property may help investors make more informed financial decisions. By reviewing comparable rental homes, studying vacancy trends, and fully accounting for ownership expenses, investors may better understand long-term rental property profits in Fayetteville, NC.

How to Estimate Rental Income Before Purchasing an Investment Property features insights from Amy Reynolds, a Property Management Expert in Fayetteville, North Carolina, on HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative "edvertising" approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article